You may have heard this advice in the past: "Buy the Generals."

That meant investing in automaker General Motors (GM), cereal giant General Mills (GIS), defense contractor General Dynamics (GD), and longtime industrial conglomerate General Electric ("GE").

For a long time, I agreed.

Years ago, I considered GE a forever stock...

It started as a sleepy business designed to sell light bulbs and help people buy kitchen appliances on credit. It was boring but stable, making it a great long-term holding.

Then GE began gobbling up practically every business it saw for sale – many having nothing to do with its core divisions. It expanded hugely into finance, eventually turning into what was essentially the seventh-largest bank in the country.

But it didn't have the same safeguards or capital sources as a traditional bank. So when the credit markets seized up during the Great Recession, GE nearly went bust... It became the "Lehman of Lightbulbs."

Despite its financial difficulties, GE remained a stalwart on the Dow Jones Industrial Average. This index is made up of 30 of America's best blue-chip industry leaders. So having your stock included is a sign your company has staying power.

I kept an eye on GE for years, thinking that it had a path to resurrect its previously dominant business... It never happened.

In 2018, GE was finally booted from the Dow, ending its 111-year run. And in 2024, the company split off into three independent entities. The General Electric that many of us knew as a household name growing up was over.

While the end of GE's historic run in the Dow made headlines, companies shuffle on and off the major indexes all the time. The S&P 500 Index, the Nasdaq Composite Index, and the Russell 2000 Index also regularly change up their rosters.

These moves reflect the changing industrial and technological landscape in the U.S. And the companies that join these indexes are often put into the spotlight for the first time... which can lead to a rising stock price.

This exact situation is set to unfold during the Russell 2000's rebalance on June 26.

My friend and colleague Joel Litman from our corporate affiliate Altimetry says a little-known Wall Street rule tied to this event could create one of the biggest short-term profit opportunities of the year...

You see, the Russell 2000 tracks 2,000 small-cap stocks. Whenever those names change, large institutions that track the index have to buy the new holdings and sell the ousted ones.

That means billions of dollars can suddenly flood into these stocks during the upcoming rebalance.

General Electric's removal from the Dow signaled the start of the company's downfall. The opposite is true for any business added to the Russell 2000 during its rebalance... It means automatic buyers for a previously overlooked company.

According to Joel, this annual process has historically created a predictable window of opportunity for fast gains – especially in small caps that can move dramatically when institutional money arrives.

Folks who act now have the chance to beat this wave of buying that's just around the corner... before Wall Street is forced to pile in.

Click here to learn more about which stocks are set to benefit most.

Now, let's get to this week's Q&A... And as always, keep sending your comments, questions, and topic suggestions to feedback@healthandwealthbulletin.com. My team and I read every e-mail.

Is Sourdough Bread Good for You?

Q: Do you consider sourdough a healthy alternative to white bread? Is it healthier like a whole wheat loaf would be? – I.L.

A: Thanks for writing in, I.L. Sourdough is a bit different than other breads that use white flour, like white bread.

Most white bread increases inflammation in your body due to excess sugar and its carbohydrates. It ranks high on the glycemic index, which means it raises your blood sugar and causes a crash afterward.

It's important to note that sugar isn't the only thing that causes blood-sugar spikes – carbohydrates can do this, too.

The good news is that sourdough bread has no sugar and is relatively low on the glycemic index. So while it will raise your blood sugar because it's a carbohydrate, you won't see a spike followed by a quick crash.

Sourdough also contains Bifidobacterium bifidum. This bacteria strain keeps harmful pathogens from entering our bloodstream and making us sick.

But I still recommend stone-ground wheat breads and sprouted grain breads over white bread or sourdough. They have more fiber and greater overall nutritional value.

Whichever type you choose, bread shouldn't make up a major part of your diet, as it generally lacks many essential nutrients. So eat any bread in limited quantities.

And the next time you pick up some bread, read the ingredients. Ideally, the No. 1 ingredient is whole grain or grains. And if you see sugar on the label, skip it.

What We're Reading...

Here's to our health, wealth, and a great retirement,

Dr. David Eifrig and the Health & Wealth Bulletin Research Team
April 17, 2026

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top